by Marwan Sabbagh, MD

The use of APOE genotyping to assess the risk of developing Alzheimer’s disease is a controversial topic among physicians. The consensus is that routine testing for asymptomatic individuals is not recommended, but some patients with a family history of the disease may be curious and request testing.

Dr. Marwan Sabbagh discusses the rising popularity of APOE genotype testing despite concerns related to the disclosure of genetic information. In our timely interview, he notes research that shows the benefits more than likely outweigh the risks, especially when tests are ordered as part of a comprehensive approach to patient care.

Check out Part 1 of Dr. Sabbagh’s interview by clicking here!